395 related articles for article (PubMed ID: 33668611)
1. The Autophagy Pathway: A Critical Route in the Disposal of Alpha 1-Antitrypsin Aggregates That Holds Many Mysteries.
Leon C; Bouchecareilh M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668611
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
Karatas E; Bouchecareilh M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
[TBL] [Abstract][Full Text] [Related]
3. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency.
Callea F; Giovannoni I; Francalanci P; Boldrini R; Faa G; Medicina D; Nobili V; Desmet VJ; Ishak K; Seyama K; Bellacchio E
Orphanet J Rare Dis; 2018 May; 13(1):79. PubMed ID: 29769092
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.
Karatas E; Raymond AA; Leon C; Dupuy JW; Di-Tommaso S; Senant N; Collardeau-Frachon S; Ruiz M; Lachaux A; Saltel F; Bouchecareilh M
JHEP Rep; 2021 Aug; 3(4):100297. PubMed ID: 34151245
[TBL] [Abstract][Full Text] [Related]
5. Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin Deficiency.
Li J; Moretti F; Hidvegi T; Sviben S; Fitzpatrick JAJ; Sundaramoorthi H; Pak SC; Silverman GA; Knapp B; Filipuzzi I; Alford J; Reece-Hoyes J; Nigsch F; Murphy LO; Nyfeler B; Perlmutter DH
Cell Mol Gastroenterol Hepatol; 2024; 17(6):1007-1024. PubMed ID: 38336172
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
7. The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease.
Khodayari N; Wang RL; Oshins R; Lu Y; Millett M; Aranyos AM; Mostofizadeh S; Scindia Y; Flagg TO; Brantly M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948056
[TBL] [Abstract][Full Text] [Related]
8. Sirtuin3 promotes the degradation of hepatic Z alpha-1 antitrypsin through lipophagy.
Poole B; Oshins R; Huo Z; Aranyos A; West J; Duarte S; Clark VC; Beduschi T; Zarrinpar A; Brantly M; Khodayari N
Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285890
[TBL] [Abstract][Full Text] [Related]
9. Modulation of calreticulin expression reveals a novel exosome-mediated mechanism of Z variant α
Khodayari N; Oshins R; Alli AA; Tuna KM; Holliday LS; Krotova K; Brantly M
J Biol Chem; 2019 Apr; 294(16):6240-6252. PubMed ID: 30833329
[TBL] [Abstract][Full Text] [Related]
10. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
Teckman JH
COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
[TBL] [Abstract][Full Text] [Related]
11. Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders.
Padilla-Godínez FJ; Ramos-Acevedo R; Martínez-Becerril HA; Bernal-Conde LD; Garrido-Figueroa JF; Hiriart M; Hernández-López A; Argüero-Sánchez R; Callea F; Guerra-Crespo M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830348
[TBL] [Abstract][Full Text] [Related]
12. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of the histological features of alpha-1 antitrypsin deficiency-associated liver disease in biopsy specimens.
Marek G; Collinsworth A; Liu C; Brantly M; Clark V
PLoS One; 2021; 16(8):e0256117. PubMed ID: 34398915
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1-antitrypsin deficiency: importance of proteasomal and autophagic degradative pathways in disposal of liver disease-associated protein aggregates.
Perlmutter DH
Annu Rev Med; 2011; 62():333-45. PubMed ID: 20707674
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1-antitrypsin.
Baligar P; Kochat V; Arindkar SK; Equbal Z; Mukherjee S; Patel S; Nagarajan P; Mohanty S; Teckman JH; Mukhopadhyay A
Hepatology; 2017 Apr; 65(4):1319-1335. PubMed ID: 28056498
[TBL] [Abstract][Full Text] [Related]
17. NFκB mitigates the pathological effects of misfolded α1-antitrypsin by activating autophagy and an integrated program of proteostasis mechanisms.
Mukherjee A; Hidvegi T; Araya P; Ewing M; Stolz DB; Perlmutter DH
Cell Death Differ; 2019 Mar; 26(3):455-469. PubMed ID: 29795336
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?
Crossley D; Stockley R; Sapey E
Drugs Aging; 2019 Sep; 36(9):823-840. PubMed ID: 31179525
[TBL] [Abstract][Full Text] [Related]
19. The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization.
Miranda E; Ferrarotti I; Berardelli R; Laffranchi M; Cerea M; Gangemi F; Haq I; Ottaviani S; Lomas DA; Irving JA; Fra A
FEBS J; 2017 Jul; 284(13):2110-2126. PubMed ID: 28504839
[TBL] [Abstract][Full Text] [Related]
20. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
